BrightEdge Ventures

About The Fund

BrightEdge Ventures is a philanthropic impact fund located in Atlanta, Georgia, dedicated to fighting cancer and advancing health equity across all communities. They operate as the mission-driven venture capital arm of the American Cancer Society, with a visionary goal to reduce cancer mortality, alleviate pain and suffering, and promote health equity. Their investment focus is on for-profit companies developing novel cancer-focused treatments, diagnostics, devices, and technologies. BrightEdge Ventures aims to profoundly impact by accelerating the American Cancer Society's goal and bolstering the commercialization of a wide array of solutions targeting cancer. Their portfolio consists of early-stage, entrepreneurial companies pushing the boundaries in cancer care, seeking to make meaningful advancements in therapeutics and technologies. In addition to providing capital, BrightEdge leverages the American Cancer Society's expertise in social drivers of health, empowering entrepreneurs through initiatives like Project HEALTH. This accelerator program is designed to address healthcare disparities, cut down access barriers, and encourage health equity by fostering innovations that enable prevention, detection, treatment, and survival of cancer. With intentional, mission-aligned impact investing, BrightEdge Ventures extends an invitation to become a part of their movement by becoming a donor, thereby not only contributing to the transformation of the cancer care landscape but also helping to create a sustainable revenue stream for the American Cancer Society. Their efforts are measured in the potential impact on millions of patients and their families annually, as highlighted in their annual reports and white papers which discuss their impact and strategic roundtable events.